Track Galera Therapeutics, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Galera Therapeutics, Inc. GRTX Open Galera Therapeutics, Inc. in new tab

0.1000 USD
Key Metrics
Earnings dateAug. 12, 2026

DCF Valuation

Tweak assumptions to recompute fair value for Galera Therapeutics, Inc. (GRTX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Galera Therapeutics, Inc. Analysis (GRTX)

United States Health Care Stock

Is Galera Therapeutics, Inc. a good investment? Galera Therapeutics, Inc. (GRTX) is currently trading at 0.1000 USD.

Earnings Schedule: Galera Therapeutics, Inc. is expected to release its next earnings report on Aug. 12, 2026.

Investor FAQ

Does Galera Therapeutics, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Galera Therapeutics, Inc.?

Galera Therapeutics, Inc. is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Aug. 12, 2026.

Company Profile

No detailed summary available for Galera Therapeutics, Inc..

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion